BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 6673465)

  • 1. [Classification of acute non-lymphocytic leukemia based on the distribution picture of peroxidase activity and cell size. Correlation between the classification and therapeutic response].
    Takubo T; Kubota Y; Oguma S; Ueda T; Shibata H; Nakamura H; Masaoka T; Yoshitake J; Ishigami S
    Nihon Ketsueki Gakkai Zasshi; 1983 Nov; 46(6):1209-15. PubMed ID: 6673465
    [No Abstract]   [Full Text] [Related]  

  • 2. Classification of acute non-lymphocytic leukemia according to the distribution picture of peroxidase activity and cell size: correlation between the classification and therapeutic response.
    Takubo T; Kubota Y; Oguma S; Ueda T; Shibata H; Nakamura H; Masaoka T; Yoshitake J; Ishigami S
    Blood Cells; 1983; 9(3):501-14. PubMed ID: 6586210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [FAB classification, response to therapy, and survival in adult patients with acute leukemia (report II)].
    Moriyama Y; Sato K; Narita M; Takeshige T; Saito H; Aoki S; Nakamori Y; Nagai K; Takizawa S; Soga N
    Rinsho Ketsueki; 1984 Oct; 25(10):1587-93. PubMed ID: 6520936
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute non-lymphoblastic leukaemia in Indian population FAB classification and response to therapy.
    Advani SH; Rao DN; Kutty PM; Gopal R; Nair CN
    Indian J Cancer; 1983; 20(3):131-6. PubMed ID: 6654380
    [No Abstract]   [Full Text] [Related]  

  • 5. [Remission induction failures in adult acute non-lymphocytic leukemia].
    Yoshida M; Furukawa Y; Akashi M; Komatsu N; Takeda K; Muroi K; Ikeda K; Ohsaka A; Ohta M; Takagi S
    Rinsho Ketsueki; 1985 Jun; 26(6):924-8. PubMed ID: 4068253
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chemotherapy and FAB classification].
    Takeuchi J
    Rinsho Ketsueki; 1992 May; 33(5):592-8. PubMed ID: 1630010
    [No Abstract]   [Full Text] [Related]  

  • 7. Proliferation kinetics and prediction of chemotherapeutic effect in adult acute leukemia according to the FAB classification.
    Tsubaki K; Horiuchi A
    Nihon Ketsueki Gakkai Zasshi; 1984 Sep; 47(6):1322-9. PubMed ID: 6542735
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acute non-lymphoblastic leukemia in children. Therapeutic results apropos of 52 cases].
    Bertheas MF; Zisovski N; Barakat C; Manel AM; Souillet G; Philippe N
    Ann Pediatr (Paris); 1984 Oct; 31(9):733-8. PubMed ID: 6596906
    [No Abstract]   [Full Text] [Related]  

  • 9. [Development and validation of models for predicting the response to intensive induction chemotherapy in acute non-lymphoblastic leukemia].
    Sanz MA; Lorenzo JI
    Sangre (Barc); 1987; 32(5):463-9. PubMed ID: 3424049
    [No Abstract]   [Full Text] [Related]  

  • 10. [Primary relapse in patients with acute leukemia after an initial 5-year period of complete remission].
    Kawashima K; Nagura E; Yamada K; Hamajima N
    Nihon Ketsueki Gakkai Zasshi; 1986 Nov; 49(7):1354-9. PubMed ID: 3825455
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of acute non lymphocytic leukemia. Results of a prospective trial of daunorubicin, arabinosylcytosine and 6-thioguanine (DAT) versus DAT plus vindesine and etoposide.
    Bandini G; Baccarani M; Cavazzini G; Battista R; Leoni F; Morra E; Comotti B; Scapoli G; Todeschini G; Mangoni L
    Haematologica; 1987; 72(5):431-7. PubMed ID: 3121465
    [No Abstract]   [Full Text] [Related]  

  • 12. [Failures of remission induction in adult acute leukemia].
    Honda T; Sampi K; Kumai R; Hattori M
    Rinsho Ketsueki; 1984 Jul; 25(7):1060-4. PubMed ID: 6502956
    [No Abstract]   [Full Text] [Related]  

  • 13. Outcome of aggressive induction therapy in acute non-lymphocytic leukaemia.
    Saikia TK; Ahuja HG; Gopal R; Nair CN; Kamat DM; Pai MR; Advani SH
    J Assoc Physicians India; 1985 Mar; 33(3):203-6. PubMed ID: 4044476
    [No Abstract]   [Full Text] [Related]  

  • 14. Leukemia.
    McKenna SJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Feb; 89(2):137-9. PubMed ID: 10673646
    [No Abstract]   [Full Text] [Related]  

  • 15. [Importance of changes in potassium in the management of patients with acute non-lymphoblastic leukemia].
    Marazuela M; Díaz-Mediavilla J; Martínez R; del Potro E; Alvarez A; Espinós D
    Med Clin (Barc); 1986 Dec; 87(20):843-6. PubMed ID: 3807453
    [No Abstract]   [Full Text] [Related]  

  • 16. Prediction of the response to chemotherapies in the patients with acute leukemias based on the initial cytogenetic analysis.
    Takeuchi J; Murakami J; Hayakawa Y
    Nihon Ketsueki Gakkai Zasshi; 1985 Dec; 48(8):1809-19. PubMed ID: 3836547
    [No Abstract]   [Full Text] [Related]  

  • 17. [DCTP (I) combination chemotherapy of adult acute non-lymphocytic leukemia].
    Kobayashi T; Ogawa M; Inagaki J; Horikoshi N; Ezaki K; Inoue K; Aiba K; Nagata T; Chinen T; Kuraishi Y; Meguro S; Ichiba K; Abe M
    Rinsho Ketsueki; 1982 Nov; 23(11):1681-8. PubMed ID: 7166808
    [No Abstract]   [Full Text] [Related]  

  • 18. [Results using current therapy programs with acute leukemias in adults].
    Perilov AA; Volkova MA; Frenkel' MA
    Vestn Akad Med Nauk SSSR; 1986; (5):18-23. PubMed ID: 3460275
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of relapsing acute leukemia].
    Yamada K; Kato Y
    Gan No Rinsho; 1983 Aug; 29(10):1092-5. PubMed ID: 6632196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute leukemia: which of two types of cell death (necrosis or apoptosis) may be responsible for patients' death during intensive chemotherapy?].
    Petukhov VI; Pavlov BN
    Ter Arkh; 2002; 74(12):100-4. PubMed ID: 12577856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.